200,000+ products from a single source!

sales@angenechem.com

Home > Applications of palladium dibenzylideneacetone as catalyst in the synthesis of five-membered N-heterocycles

Applications of palladium dibenzylideneacetone as catalyst in the synthesis of five-membered N-heterocycles


Navjeet Kaur
Department of Chemistry, Banasthali Vidyapith, Banasthali, Rajasthan, India

 

Introduction
Heterocycles are very important not only industrially and biologically but also for the functioning of any developed human society.[1,2] The largest classical divisions of organic chemistry are constituted by heterocycles. Many pharmaceutically active compounds and natural products contain heterocycle moieties.[3,4] Transition metal catalyzed reactions are most attractive protocols among a number of new synthetic methodologies because multiply substituted molecules were constructed directly under mild conditions from easily available starting substrates. The development of newer transformations for heterocycle syntheses using atom economical and efficient pathways is a popular research area nowadays.[5–7] One of the most powerful and useful tool in organic synthesis is metal coupling transformation now. Heteroannulation with metal is a convenient and useful method for the synthesis of sulfur containing heterocycles.[8,9]

 

There is a need for the development of rapid, efficient and versatile strategy for the synthesis of heterocyclic rings. Metal involving methods have gained prominence because traditional conditions have disadvantages such as long reaction times, harsh conditions and limited substrate scopes. In the past decade, metal complexes involving heterocyclic synthesis have become of common use because complicated molecules can be directly built by a metal-assisted reaction under mild conditions from commercial available starting materials.[10–14]

 

Palladium has a rich organometallic chemistry which has developed over the past 25 years. For products with a high added value, this approach can be cost effective, in that palladium is much cheaper than platinum or rhodium, and high recoveries of palladium can be achieved. The redox behavior of palladium plays an important role in its relevance to organic synthesis, there are at least three other characteristics which enrich the organic chemistry of palladium.
i. The facile rearrangement of trihapto into monohapto ally1 complexes, which creates co-ordinative unsaturation at the metal center and enhances reactivity.
ii. The ability of nucleophile to attack at either metal or ligand sites selectively.
iii. The kinetic lability of palladium-carbon monoxide species which enables carbon monoxide to insert into other palladium-carbon bonds. Among these palladium catalysts, palladium dibenzylideneacetone catalyst is preferred due to following reasons:
I. The reaction proceeds in one step with high regioselective and stereoselective control.
II. The reaction occurs under mild conditions and is not affected by water or air, however if organophosphines are present an inert atmosphere should be used.
III. The reaction is tolerant of most functionalities.[15]
Synthesis of heterocyclic compounds in the presence of transition metal complexes has become common because a metal-catalyzed reaction can form complicated molecules directly from easily available starting materials under mild conditions.[16] In this review, I have focused on the synthesis of several five-membered heterocyclic compounds with nitrogen as the heteroatom in the presence of palladium dibenzylideneacetone catalysts.


Palladium bis(dibenzylideneacetone)-catalyzed synthesis of five-membered N-heterocycles Kundig et al.[17,18] described the Pd-catalyzed intramolecular a-arylation reactions in the presence of chiral NHC ligands.[19,20] The most successful NHC ligand was examined from this work in Wacker-type oxidative cyclization reactions which afforded the first highly-enantioselective reaction (>90% ee) using a chiral NHC-Pd catalyst (Scheme 1).

 

The a-arylation of carbonyl compounds was least investigated transformation, among the several palladium-catalyzed coupling reactions for the formation of C–C bonds, although it was a useful and simple process to synthesize interesting compounds. This simple cross-coupling reaction in the presence of a transition metal catalyst was independently reported by the groups of Hartwig[23] and Buchwald[24] in 1997 which involved a ketone enolate and an aryl halide. Muratake and Natsume[25] at the same time reported the intramolecular a-arylation to synthesize cyclic complex molecules by this short and convenient pathway. Many groups have used chiral N-heterocyclic carbenes in asymmetric intramolecular a-arylation. Hartwig et al.[26] in 2001 first attempted the enantioselective palladium-catalyzed intramolecular reaction of enolates and aromatic bromide in the presence of three different monodentate chiral imidazolium salts. Moderate to good yields of enantioenriched oxindoles were obtained (Scheme 2). With imidazolium salt, the highest selectivity (76% ee) was achieved, which possessed the (þ)-bornyl pattern, the stereogenic center was closer than the (–)-isopinocamphenyl structure. With chiral NHC-ligands the stereoselectivity remained modest and as compared to well-established chiral phosphines like Duphos, BINAP, and Josiphos best result was reported in this field. Glorius et al.[19] in 2002 constructed a C2-symmetric monodentate NHC possessing a two-chiral oxazoline pattern.

 

Nevertheless, only moderate yields were observed by enantioselective palladiumcatalyzed intramolecular a-arylation. Douthwaite et al.[27] have also performed this reaction with a trans-1,2 diaminocyclohexane spacer/linker containing C2-symmetric diimidazolium salt. However, low selectivity (11% ee) was observed with palladium complex PdCl2.

 

A variety of nitrogen containing aromatic heterocycles such as benzimidazoles, indoles, quinolines, and pyrrozoles were synthesized by intramolecular C–N bond formation. Watanabe[28] reported an early example for the synthesis of indoles by an intramolecular cyclization of hydrazones with o-chloroarenes (Scheme 3). The reaction occurred from the enamine tautomer through an intramolecular C–N bond formation. This reaction occurred in good yields with bulky electron rich phosphine ligands like t-Bu3P. The enamines and simple imines along with hydrazones also underwent similar cyclizations to synthesize indoles.[29,30] The 1-aminoindoles without substituents in 2 and 3 position were synthesized by cyclization of N,N-dimethylhydrazones of arylacetaldehydes in the presence of phosphane and Pd(dba)2. [31] The chlorine was substituted directly in N,N-dimethylhydrazones of arylacetaldehydes in the presence of an azole, an amine or an arylboronic acid.

 

Tetracyclic oxazolocarbazoles (functionalized precursors of carbazoquinocins and antiostatins), hyellazole and carazostatin (polysubstituted carbazole alkaloids), 2-arylindole NK1 receptor antagonists, and vincadifformine and (-)-tabersonine (prominent members of aspirioderma alkaloids) contain indole moiety.[32–35] The isocyanade was transformed into indole by a one-pot synthetic protocol through in situ formed 2-iodoindole[36] (Scheme 4). An intramolecular Stille coupling was also reported for an indole synthesis.[37–44]

 

Tan and Hartwig[45] reported the amination of arenes with oxime acetates. Under Pd catalysis with Cs2CO3, numerous 2,3-disubstituted indoles were prepared at high temperature and long reaction times (Scheme 5). Moderate yields were obtained for all oxime substrates regardless of sterics and electronics (40–71%). Interestingly, m-OMe substituted oxime was cyclized on the more hindered C–H bond with complete selectivity in high yield (71%). A Pd(II) complex, resulting from N–O oxidative addition, was isolated, characterized and shown to proceed to the desired product upon heating with a base. With this result, the authors suggested that the oxidative addition was the first step, followed by C–H bond insertion and reductive elimination to afford the indole product. Although not mentioned by the authors, the intermediacy of a Pd-nitrene, similar to Buchwald’s proposal for his Cu transformation, should also be viable since the stoichiometric studies cannot rule out this possibility. Following oxidative addition, the Pd species can also form a Pd-nitrene upon elimination of acetic acid; subsequently Pd-nitrene amination afforded the product as well. Soderberg et al.[46,47] reported the synthesis of indoles containing an electron-donating alkoxy group in the 3-position from o-nitrostyrenes through N-heterocyclization (Scheme 6).


Palladium tris(dibenzylideneacetone)-catalyzed synthesis of five-membered N-heterocycles
The resin-bound 2-bromophenylacetylated amino acids were used for the solid-phase synthesis of indolines. The secondary amines were formed by reduction of solid-support bound amides with borane. The formed secondary amines by intramolecular cyclization in the presence of palladium catalyst and on cleavage afforded the corresponding disubstituted indulines (Scheme 7).


Di-palladium tris(dibenzylideneacetone)-catalyzed synthesis of five-membered N-heterocycles
Functionalized indoles at C-2 position were synthesized from o-(2,2-dibromovinyl)phenylacetanilide through domino palladium-catalyzed coupling cyclization reaction (Scheme 8).[49] The indole was synthesized through Suzuki coupling which needed the acetanilide derivative (with Boc derivative or free aniline unsatisfactory results were obtained) and Pd2(dba)3 instead of Pd(OAc)2. The o-(2,2-dibromovinyl)-aniline was transformed into a 2-substituted indole by some similarities in a mechanism to that of the last step of the Larock indole synthesis. Different reactivity of the two C–Br bonds in oxidative addition benefited this tandem process.[50,51] The bromovinyl aniline was formed in a first step through Suzuki coupling with substitution of the more reactive trans-bromine atom, then the formed bromovinyl aniline underwent Pd catalyzed intramolecular C–N bond formation. The phosphonylated 2-indolyl derivative was also prepared by this similar method. Moreover, the synthesis of benzofurans was also reported in the same publication using a phenol instead of aniline derivative.[44,52]

 

The N-fragments were introduced in a single-step cascade sequence onto an acyclic carbon framework for the synthesis of N-functionalized indoles through new palladiumcatalyzed pathway. The o alkynylhaloarenes, (o-haloalkenyl)aryl halides, and gem-dihaloalkenylarenes were developed originally as indole precursors. Willis et al.[53,54] explored the alkenyl triflate substrates and reported that dihalides underwent tandem intermolecular N-alkenylation and intramolecular N-arylation to form indoles. The N-substituted products were afforded in excellent yields in the presence of palladiumbased catalytic system (Scheme 9). Both the E- and the Z-isomers of the starting alkenyl halides were utilized. High yields were also obtained with dichloro substrates. A chloro substituent was introduced at each position of the benzo ring to form the products which were suitable for further synthetic elaboration.[55] Willis et al.[56] used pyridinebased starting compounds for the synthesis of 7-azaindoles. Good yields of products were afforded under similar conditions that were used for the preparation of parent indole. The sterically demanding N-substituents bearing indoles like N-(reverse prenyl)indole were also prepared.[57] The synthesis of natural product demethylasterriquinone A by this approach demonstrated the synthetic utility of this process in which N-(reverse prenyl)indole was used as a key intermediate. The cascade coupling of the vinyl-triflate and aryl-halide bonds in styrene with primary amines formed the indoles.

 

This reaction occurred with a number of primary amines, carbamates and amides in the presence of a single palladium catalyst (Pd2dba3/Xantphos), despite the fact that two different types of C–X bonds must be activated. It has been found that even vinyl-chlorides participated in this coupling reaction.

 


Many reactions have been reported for the preparation of indol derivatives.[59] The anti-Markovnikov hydroamination of o-chloro-substituted 2-alkyl-1-arylalkynes produced arylethylimines by a one-pot synthetic route. The 1,2-disubstituted indoles were synthesized by direct Buchwald-Hartwig coupling of the imine through the formation of tautomeric enamine intermediate under basic conditions (Scheme 10).[60] The substituted benzo[b]furans were accessed through copper-catalyzed O-arylation of ketones formed through hydrolysis of the arylethylimines.[61,62]

 

Doye and coworkers[60] reported the one-pot synthesis of N-alkyl and N-arylindoles from 1-(o-chloroaryl)-2-alkyl alkynes which involved the formation of two new C–N bonds (Scheme 11). The alkynes underwent regioselective hydroamination with a primary amine to form imines in the presence of titanium catalyst. The imines were in equilibrium with enamines. Subsequently, the enamines were converted into indoles in good yield by a palladium-catalyzed intramolecular C–N bond forming reaction when the 1,3-bis(2,4,6-trimethylphenyl)imidazolium chloride (precursor of a carbene ligand), Pd2(dba)3, and t-BuOK were added directly to the reaction mixture. The indole was afforded in modest yield (39%) only when the 2-vinyl alkyne was reacted with tertbutylamine, this was due to the worse regioselectivity of the titanium-catalyzed hydroamination of 2-vinyl alkynes in comparison to 2-alkyl alkynes. The scope of this reaction was expanded for the synthesis of cyclic indole derivatives from 1-(o-chloroaryl)-2-(aminoalkyl)alkynes precursors. An intramolecular hydroamination occurred through titanium catalyzed protocol in this case.

 

This protocol was extended for the formation of functionalized pyrrole on heteroaromatic scaffolds which offered a new access to pyrroloquinoxaline[63] and azaindole[64] derivatives. In the aminopalladation-reductive elimination alkyl halides such as benzyl bromides and ethyl iodoacetate were also employed for the synthesis of indoles to form the 2-substituted 3-benzylindoles and indolylcarboxylate esters.[65,66] The reaction of heteroaryl, aryl and triflates, or vinyl halides successfully formed the 2,3-disubstituted indoles under the conditions,[67–70] under these same conditions the reaction was unsuccessful and afforded the N-alkyl derivative as main or sole product through a competitive nucleophilic substitution reaction. Noteworthy, the 2-acyl-3-alkylindoles were synthesized from N-alkyl intermediates.[71] The role of bases, ligands, and solvents was investigated to obtain the best results by using Pd2(dba)3, K2CO3, and electron-rich, strongly basic, sterically encumbered ligan tris(2,4,6-trimethoxyphenyl)phosphine (ttmpp)[72] at 80 C in THF. A number of o-alkynyltrifluoroacetanilides were transformed into the desired indole products in satisfactory yields and good selectivity was observed in favor of the palladium-catalyzed cyclization under these conditions (Scheme 12). Similar results were observed with benzyl bromides. The solvent played an important role in this reaction.

 

For instance, when all the other parameters were kept same and dimethylsulfoxide (DMSO) solvent and o- (phenylethynyl)trifluoroacetanilide were used the indole carboxylate ester was formed in only 12% yield, whereas 64% yield of 2-ethoxycarbonyl-3-benzylindole was reported.[44,49b] Proper conditions were developed for the indolization by the reaction of o-bromoaniline and a-bromostyrene (Scheme 13). The imine was afforded always without indole formation in the presence of BINAP (for the amination of vinyl bromides BINAP is a ligand of choice). When a more active ligand, like bulky electron-rich phosphine DavePhos, was used, the reaction was promoted and indolization occurred with good yield.[52,73]

 

Itoh and coworkers[74] described the palladium(0)-catalyzed intramolecular cyclotrimerization. Highly substituted dihydroisoindole derivatives were afforded when electron-deficient dialkynes were reacted with DMAD in the presence of Pd2(dba)3 and PPh3 (Scheme 14). Moderate yields of phthalin and isoindoline derivatives were reported by this method. This method was efficiently extended to intramolecular cyclization of triynes to form the tricyclic aromatic systems.[75]

 

To overcome the nonproductive b-hydride elimination, insertions of alkenes were combined with a fast second reductive elimination step in contrast to carbopalladation sequences of alkynes. Wolfe et al.[76] with the help of this concept have discovered a three component reaction with sequential N-arylation and carbopalladation as elementary steps. The N-arylation produced an alkene-coordinated aryl palladium complex.

 

The indoline was formed by inserting olefin fragment followed by a reductive elimination (Scheme 15). The nonvolatile, simple, achiral starting material 2-allylaniline was employed. This transformation afforded unsatisfactory results in the presence of dppe or dppb ligands again. However, N-phenyl-2-benzylindoline was formed in 92% yield using Dpe-phos as a ligand.[77] High yields of N-aryl-2 benzylindoline derivatives were also obtained by coupling a wide range of other aryl bromides with 2-allylaniline.[78,79] Author’s prepared two identical aryl groups possessing indolines successfully and it
prompted them to explore the synthesis of two different aryl groups containing related compounds. However, a mixture of mono- and diarylated products was furnished by reacting 2-allylaniline with 1 Eq. of 2-bromonaphthalene. In the presence of (t-Bu)2P(obiphenyl) ligand, high selectivity was observed for monoarylated product (Scheme 16).

 

The heteroatom possessing bis-allylpalladium analogs were reacted by extending the reaction of bis-allylation. The 2-alkynylisocyanobenzenes, allyl methyl carbonate, and trimethylsilyl azide were reacted by palladium-catalyzed three-component coupling reaction to afford good yields of N-cyanoindoles (Scheme 17).[84] The reaction proceeded through the formation of allylpalladium azide, and subsequently the allylpalladium intermediate was produced by the insertion of divalent carbon of isocyanide into the NPd bond of allylpalladium azide. The allylpalladium intermediate eliminated the nitrogen to form the bis-allylpalladium analog (3-allyl)(3-cyanamido)palladium complex.

 

Yamamoto et al.[85,86] synthesized 2-substituted 3-allylindoles through cyclization of alkynylbenzenes possessing isocyano and isocyanato moieties in the ortho position. The 2-substituted 3-allyl-N-cyanoindoles were formed when o-alkynylisocyanobenzenes, allyl methyl carbonate, and trimethylsilyl azide were reacted through a three-component reaction in Pd2(dba)3.3CHCl3 and tri(2-furyl)phosphine at 100 C. With a number of substituents in the aryl ring good to allowable yields were reported. The Curtius-like rearrangement of p-allylpalladiumintermediate to the palladium-carbodiimide complex
was a distinctive and interesting aspect of this mechanism. The palladium-carbodiimide and palladium-cyanamide complexes were in equilibrium. The presence of heteroatom possessing bis-p-allylpalladium complex was also suggested. The insertion of alkyne functionality into the Pd-N bond of intermediate followed by a reductive elimination of Pd(0) formed the N-cyanoindole. At 100 C temperature indoles were obtained whereas, reductive elimination of Pd(0) from the palladium-cyanamide complex occurred to produce allyl cyanamides at lower temperature (up to 40 C).[13,44]
Barluenga et al.[87] synthesized indole derivatives by a three-component reaction. This strategy involved a Pd-catalyzed cascade sequence which involved an alkenyl amination, C-arylation and a subsequent intramolecular N-arylation. During the start of the reaction equimolecular amounts of haloalkene, o-dihaloarene, and amines were mixed. The higher reactivity of haloalkene as compared to the haloarene towards the oxidative addition with palladium allowed the unique synthesis of imine intermediate. Further the deprotonation in basic media produced the corresponding aza-allylic anion. The 2-substituted indoles were formed in a subsequent Pd-assisted intermolecular alkylation with the dihalogeno substrate followed by an intramolecular N-arylation. The palladium catalyst was intervened in three different coupling reactions in this cascade reaction. Those three coupling reactions were: intermolecular N-alkenylation, C-arylation, and intramolecular N-arylation (Scheme 18).[88]
 

Over 100,000 products now available from Angene:

CAS No. 102192-40-5

2,4-Pentanedione, ion(1-), thorium (1:1)

Catalog No.:AG0006VN MDL No.:

MF: MW:

CAS No. 102192-59-6

9(2H)-Acridinone, 7-chloro-3-(2,4-dichlorophenyl)-1-[(2,6-dimethyl-1-piperidinyl)imino]-1,3,4,10-tetrahydro-10-hydroxy-

Catalog No.:AG0006VM MDL No.:

MF:C26H26Cl3N3O2 MW:518.8625

CAS No. 102192-66-5

Benzaldehyde, 2-[7-chloro-3,4,9,10-tetrahydro-10-hydroxy-9-oxo-3-[4-(trifluoromethyl)phenyl]-1(2H)-acridinylidene]hydrazone

Catalog No.:AG0006VL MDL No.:

MF:C27H19ClF3N3O2 MW:509.9069

CAS No. 102193-00-0

6,9-Diazoniadispiro[5.2.5.3]heptadecane, iodide (1:2)

Catalog No.:AG0006VK MDL No.:

MF:C15H30I2N2 MW:492.2210

CAS No. 1022-04-4

1H-Indole, 7-methoxy-3-(2-nitro-1-propen-1-yl)-

Catalog No.:AG0006WB MDL No.:

MF:C12H12N2O3 MW:232.2353

CAS No. 1022-07-7

Benzenamine, N-methyl-2,4,6-trinitro-

Catalog No.:AG0006WA MDL No.:

MF:C7H6N4O6 MW:242.1457

CAS No. 1022-13-5

Methanone, [5-chloro-2-(methylamino)phenyl]phenyl-

Catalog No.:AG0006W9 MDL No.:MFCD00008284

MF:C14H12ClNO MW:245.7042

CAS No. 1022-19-1

Piperidine, 1-(1,1-dioxidobenzo[b]thien-3-yl)-

Catalog No.:AG0006W8 MDL No.:

MF:C13H15NO2S MW:249.3287

CAS No. 1022-21-5

1,1'-Biphenyl, 2-[(trimethylsilyl)oxy]-

Catalog No.:AG0006W7 MDL No.:

MF:C15H18OSi MW:242.3883

CAS No. 1022-31-7

Benzenebutanoic acid, α-amino-2-(formylamino)-γ-oxo-

Catalog No.:AG0006W6 MDL No.:

MF:C11H12N2O4 MW:236.2240

CAS No. 1022-44-2

4-Quinazolinamine, 2-phenyl-

Catalog No.:AG0006W5 MDL No.:MFCD03093373

MF:C14H11N3 MW:221.2572

CAS No. 1022-45-3

4(3H)-Quinazolinone, 2-phenyl-

Catalog No.:AG0006W4 MDL No.:MFCD00451430

MF:C14H10N2O MW:222.2420

CAS No. 1022-55-5

3-Thiazolidineacetic acid, 5-(3-isoxazolylmethylene)-4-oxo-2-thioxo-

Catalog No.:AG0006W2 MDL No.:

MF:C9H6N2O4S2 MW:270.2849

CAS No. 1022-66-8

2(1H)-Quinolinone, 3,4-dihydro-3-phenyl-

Catalog No.:AG0006W1 MDL No.:MFCD09040531

MF:C15H13NO MW:223.2698

CAS No. 1022-78-2

4H-1-Benzopyran-4-one, 3-acetyl-5,7-dihydroxy-2-methyl-

Catalog No.:AG0006W0 MDL No.:

MF:C12H10O5 MW:234.2048

CAS No. 1022-79-3

Cytidine, 5-bromo-2'-deoxy-

Catalog No.:AG0006VZ MDL No.:MFCD00047496

MF:C9H12BrN3O4 MW:306.1133

CAS No. 10220-04-9

Thiourea, N-ethyl-N'-methyl-

Catalog No.:AG0006VY MDL No.:MFCD03208720

MF:C4H10N2S MW:118.2006

CAS No. 10220-13-0

Thiourea, N,N'-bis(3,4-dichlorophenyl)-

Catalog No.:AG0006VX MDL No.:

MF:C13H8Cl4N2S MW:366.0930

CAS No. 10220-22-1

Pyrrolidine, 1-(4-nitrophenyl)-

Catalog No.:AG0006VW MDL No.:MFCD00020819

MF:C10H12N2O2 MW:192.2145

CAS No. 10220-23-2

Morpholine, 4-(2-methoxyethyl)-

Catalog No.:AG0006VV MDL No.:MFCD16038734

MF:C7H15NO2 MW:145.1995

CAS No. 10220-27-6

4-Thiazolidinone, 2-phenyl-

Catalog No.:AG0006VU MDL No.:

MF:C9H9NOS MW:179.2389

CAS No. 10220-28-7

4-Thiazolidinone, 3-methyl-2-phenyl-

Catalog No.:AG0006VT MDL No.:

MF:C10H11NOS MW:193.2654

CAS No. 10220-42-5

2,3,7-Trithia-5,6-diazabicyclo[2.2.1]hepta-4,6-diene

Catalog No.:AG0006VS MDL No.:

MF:C2N2S3 MW:148.2298

CAS No. 10220-46-9

Acetic acid, 2-mercapto-, octadecyl ester

Catalog No.:AG0006VR MDL No.:MFCD00022084

MF:C20H40O2S MW:344.5954

CAS No. 10220-65-2

Propanoic acid, 3-(benzoylthio)-, ethyl ester

Catalog No.:AG0006VQ MDL No.:

MF:C12H14O3S MW:238.3028

CAS No. 10220-98-1

Benzenecarbothioamide, N-cyclohexyl-

Catalog No.:AG0006VP MDL No.:

MF:C13H17NS MW:219.3458

CAS No. 102200-79-3

1,6-Naphthyridine-3-carboxylic acid, 5,6,7,8-tetrahydro-4-hydroxy-6-(phenylmethyl)-, ethyl ester

Catalog No.:AG0006VO MDL No.:

MF:C18H20N2O3 MW:312.3630

CAS No. 102201-13-8

Benzene, 1-chloro-4-(1,1-dichloro-2,2,2-trifluoroethoxy)-

Catalog No.:AG0006X0 MDL No.:

MF:C8H4Cl3F3O MW:279.4710

CAS No. 102201-76-3

Benzene, (3-buten-1-ylsulfinyl)-

Catalog No.:AG0006WZ MDL No.:

MF:C10H12OS MW:180.2667

CAS No. 102202-74-4

1,4,7,10-Tetraazacyclododecane, 1,4,7,10-tetrakis(2-methoxyethyl)-

Catalog No.:AG0006WY MDL No.:

MF:C20H44N4O4 MW:404.5878

CAS No. 1022024-04-9

4-Piperidinol, 1-[(2,4-dichlorophenyl)sulfonyl]-

Catalog No.:AG0006WD MDL No.:MFCD21098949

MF:C11H13Cl2NO3S MW:310.1968

CAS No. 102203-10-1

Carbamimidothioic acid, 4-[(aminoiminomethyl)amino]butyl ester

Catalog No.:AG0006WX MDL No.:

MF:C6H15N5S MW:189.2818

CAS No. 102203-15-6

Carbamimidothioic acid, [2-[(phenylmethyl)thio]ethyl]-, 3-(1H-imidazol-4-yl)propyl ester (9CI)

Catalog No.:AG0006WW MDL No.:

MF:C16H22N4S2 MW:334.5027

CAS No. 102203-18-9

Carbamimidothioic acid, 2-(1H-imidazol-5-yl)ethyl ester

Catalog No.:AG0006WV MDL No.:

MF:C6H10N4S MW:170.2354

CAS No. 102203-61-2

Benzoic acid, 4-(mercaptomethyl)-, methyl ester

Catalog No.:AG0006WU MDL No.:MFCD14631594

MF:C9H10O2S MW:182.2395

CAS No. 1022059-55-7

Benzoic acid, 2-bromo-4-methyl-, hydrazide

Catalog No.:AG0006WC MDL No.:MFCD03425674

MF:C8H9BrN2O MW:229.0739

CAS No. 102206-47-3

Hydrazinecarbothioamide, 2-[[6-[3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propyl]-2-pyridinyl]methylene]-

Catalog No.:AG0006WT MDL No.:

MF:C11H10F6N4OS MW:360.2787

CAS No. 102206-54-2

Ethanamine, N,N-diethyl-2-(3-pyridinylmethoxy)-

Catalog No.:AG0006WS MDL No.:

MF:C12H20N2O MW:208.3000

CAS No. 102206-56-4

2-Propanamine, N,N-diethyl-1-(3-pyridinylmethoxy)-

Catalog No.:AG0006WR MDL No.:

MF:C13H22N2O MW:222.3266

CAS No. 102206-57-5

2-Propanamine, N,N-diethyl-1-[(3-pyridinylmethyl)thio]-

Catalog No.:AG0006WQ MDL No.:

MF:C13H22N2S MW:238.3922

CAS No. 102206-63-3

Pyridine, 3-[(ethylthio)methyl]-

Catalog No.:AG0006WP MDL No.:

MF:C8H11NS MW:153.2446

CAS No. 102206-77-9

3,4,5-Pyridinetricarbonitrile, 2-amino-6-[[2-(diethylamino)ethyl]amino]-

Catalog No.:AG0006WO MDL No.:

MF:C14H17N7 MW:283.3317

CAS No. 102206-78-0

3,4,5-Pyridinetricarbonitrile, 2-amino-6-(dimethylamino)-

Catalog No.:AG0006WN MDL No.:

MF:C10H8N6 MW:212.2107

CAS No. 102206-79-1

3,4,5-Pyridinetricarbonitrile, 2-amino-6-(methoxymethylamino)-

Catalog No.:AG0006WM MDL No.:

MF:C10H8N6O MW:228.2101

CAS No. 102206-80-4

3,4,5-Pyridinetricarbonitrile, 2-amino-6-[(3-methoxypropyl)amino]-

Catalog No.:AG0006WL MDL No.:

MF:C12H12N6O MW:256.2633

CAS No. 102206-81-5

3,4,5-Pyridinetricarbonitrile, 2-amino-6-(1-naphthalenylamino)-

Catalog No.:AG0006WK MDL No.:

MF:C18H10N6 MW:310.3122

CAS No. 102206-87-1

Pyridinium, 1-[[(1-oxo-10-undecen-1-yl)amino]methyl]-, chloride (1:1)

Catalog No.:AG0006WJ MDL No.:

MF:C17H27ClN2O MW:310.8621

CAS No. 102207-08-9

Piperidine, 1-[(1-phenylcyclopentyl)methyl]-

Catalog No.:AG0006WI MDL No.:

MF:C17H25N MW:243.3871

CAS No. 102207-22-7

Piperidinium, 1-(2-cyanoethyl)-1-(2-oxo-2-phenylethyl)-, bromide (1:1)

Catalog No.:AG0006WH MDL No.:

MF:C16H21BrN2O MW:337.2547

CAS No. 102207-27-2

Piperidinium, 1-[2-(diethylamino)-2-oxoethyl]-4-formyl-1-methyl-4-phenyl-, iodide (1:1)

Catalog No.:AG0006WG MDL No.:

MF:C19H29IN2O2 MW:444.3502

CAS No. 102207-29-4

Piperidinium, 3-[(diphenylmethoxy)methyl]-1,1-dimethyl-, bromide (1:1)

Catalog No.:AG0006WF MDL No.:

MF:C21H28BrNO MW:390.3571

CAS No. 102207-30-7

Piperidinium, 4-(hydroxymethyl)-1,1-dimethyl-, iodide (1:1)

Catalog No.:AG0006XP MDL No.:

MF:C8H18INO MW:271.1391

CAS No. 102207-31-8

Piperidinium, 1-[2-(2,2-diphenylethoxy)ethyl]-1-methyl-, iodide (1:1)

Catalog No.:AG0006XO MDL No.:

MF:C22H30INO MW:451.3842

CAS No. 102207-35-2

Piperidinium, 1-methyl-1-[2-(methylphenylamino)ethyl]-, bromide (1:1)

Catalog No.:AG0006XN MDL No.:

MF:C15H25BrN2 MW:313.2764

CAS No. 102207-38-5

Piperidinium, 1-methyl-1-[tetrahydro-4-(2-thienyl)-2H-thiopyran-4-yl]-, iodide (1:1)

Catalog No.:AG0006XM MDL No.:

MF:C15H24INS2 MW:409.3922

CAS No. 102207-55-6

Pyridine, 3-[[(phenylmethyl)thio]methyl]-

Catalog No.:AG0006XL MDL No.:

MF:C13H13NS MW:215.3140

CAS No. 102207-69-2

4-Pyrimidinamine, 6-chloro-5-hexyl-2-methyl-

Catalog No.:AG0006XK MDL No.:

MF:C11H18ClN3 MW:227.7337

CAS No. 102207-71-6

4-Pyrimidinamine, 6-chloro-2-methyl-5-pentyl-

Catalog No.:AG0006XJ MDL No.:

MF:C10H16ClN3 MW:213.7071

CAS No. 102207-75-0

2-Pyrimidinamine, 4-[2-(diethylamino)ethoxy]-

Catalog No.:AG0006XI MDL No.:

MF:C10H18N4O MW:210.2761

CAS No. 102207-78-3

2-Pyrimidinamine, 4-[2-(dioctylamino)ethoxy]-

Catalog No.:AG0006XH MDL No.:

MF:C22H42N4O MW:378.5951

CAS No. 102207-80-7

5-Pyrimidinecarboxylic acid, 1,2,3,4-tetrahydro-6-methyl-2-oxo-4-phenyl-, 1-(phenylamino)ethyl ester

Catalog No.:AG0006XG MDL No.:

MF:C20H21N3O3 MW:351.3990

CAS No. 102207-81-8

4-Pyrimidinamine, 2-[(3-chlorophenoxy)methyl]-N,N-diethyl-6-methyl-, hydrochloride (1:1)

Catalog No.:AG0006XF MDL No.:

MF:C16H21Cl2N3O MW:342.2634

CAS No. 102207-84-1

Acetamide, 2-[2-(diethylamino)ethoxy]-N-(2,6-dimethylphenyl)-, hydrochloride (1:1)

Catalog No.:AG0006XE MDL No.:

MF:C16H27ClN2O2 MW:314.8508

CAS No. 102207-85-2

Acetamide, N-[2-(diethylamino)ethyl]-N-[2-[(2,6-dimethylphenyl)amino]-2-oxoethyl]-, hydrochloride (1:1)

Catalog No.:AG0006XD MDL No.:

MF:C18H30ClN3O2 MW:355.9027

CAS No. 102208-23-1

D-Alanine, N-(3,5-dinitrobenzoyl)-

Catalog No.:AG0006XC MDL No.:

MF:C10H9N3O7 MW:283.1944

CAS No. 102208-93-5

2H-Pyran, tetrahydro-2-methyl-6-[(1E)-2-phenylethenyl]-, (2S,6R)-

Catalog No.:AG0006XB MDL No.:

MF:C14H18O MW:202.2921

CAS No. 102208-94-6

Ethanone, 1-phenyl-2-[(2R,6S)-tetrahydro-6-methyl-2H-pyran-2-yl]-

Catalog No.:AG0006XA MDL No.:

MF:C14H18O2 MW:218.2915

CAS No. 1022083-88-0

1H-Benzimidazole, 6-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-, magnesium salt (2:1)

Catalog No.:AG0006X9 MDL No.:

MF:C32H30F4MgN6O8S2 MW:791.0446

CAS No. 1022091-46-8

6-Quinolineacetic acid, 5,7-difluoro-

Catalog No.:AG0006X8 MDL No.:

MF:C11H7F2NO2 MW:223.1756

CAS No. 1022091-49-1

Quinoline, 6-bromo-5,7-difluoro-

Catalog No.:AG0006X7 MDL No.:MFCD12828677

MF:C9H4BrF2N MW:244.0356

CAS No. 1022091-54-8

6-Quinolineacetic acid, 7-fluoro-

Catalog No.:AG0006X6 MDL No.:MFCD17011786

MF:C11H8FNO2 MW:205.1851

CAS No. 1022091-89-9

6-Quinolineacetic acid, 3-bromo-, methyl ester

Catalog No.:AG0006X5 MDL No.:MFCD26398873

MF:C12H10BrNO2 MW:280.1173

CAS No. 1022091-93-5

6-Quinolineacetic acid, 3-bromo-

Catalog No.:AG0006X4 MDL No.:MFCD17215805

MF:C11H8BrNO2 MW:266.0907

CAS No. 1022092-10-9

6-Quinolineacetic acid, 3-bromo-5,7-difluoro-, methyl ester

Catalog No.:AG0006X3 MDL No.:

MF:C12H8BrF2NO2 MW:316.0982

CAS No. 1022092-31-4

2-Butanone, 1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]-

Catalog No.:AG0006X2 MDL No.:MFCD16659790

MF:C13H21BN2O3 MW:264.1284

CAS No. 1022092-33-6

1H-Pyrazole-1-propanenitrile, 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-

Catalog No.:AG0006X1 MDL No.:MFCD16660233

MF:C12H18BN3O2 MW:247.1012

CAS No. 1022093-98-6

4-Morpholinecarboxylic acid, 3-methyl-, 1,1-dimethylethyl ester, (3R)-

Catalog No.:AG0006Y4 MDL No.:MFCD16038029

MF:C10H19NO3 MW:201.2628

CAS No. 1022094-01-4

4-Morpholinecarboxylic acid, 3-methyl-, 1,1-dimethylethyl ester, (3S)-

Catalog No.:AG0006Y3 MDL No.:MFCD12964052

MF:C10H19NO3 MW:201.2628

CAS No. 1022094-03-6

Morpholine, 3-methyl-, hydrochloride (1:1), (3S)-

Catalog No.:AG0006Y2 MDL No.:MFCD18382512

MF:C5H12ClNO MW:137.6079

CAS No. 1022094-05-8

Piperazine, 1,3-dimethyl-, hydrochloride (1:1)

Catalog No.:AG0006Y1 MDL No.:

MF:C6H15ClN2 MW:150.6497

CAS No. 1022094-18-3

8-Quinolinol, 4-chloro-, 8-(4-methylbenzenesulfonate)

Catalog No.:AG0006Y0 MDL No.:MFCD21603859

MF:C16H12ClNO3S MW:333.7894

CAS No. 10221-02-0

Morpholine, 4,4'-[thiobis(methylene)]bis-

Catalog No.:AG0006YE MDL No.:

MF:C10H20N2O2S MW:232.3430

CAS No. 10221-09-7

Benzene, 1,4-bis(bromomethyl)-2-chloro-

Catalog No.:AG0006YD MDL No.:

MF:C8H7Br2Cl MW:298.4022

CAS No. 10221-50-8

2-Heptenoic acid, 7-hydroxy-, methyl ester, (2E)-

Catalog No.:AG0006YC MDL No.:

MF:C8H14O3 MW:158.1950

CAS No. 10221-57-5

Propane, 1,2-diethoxy-

Catalog No.:AG0006YB MDL No.:

MF:C7H16O2 MW:132.2007

CAS No. 102210-76-4

2-Buten-1-one, 3-methyl-1-[1-(phenylsulfonyl)-1H-indol-2-yl]-

Catalog No.:AG0006YA MDL No.:

MF:C19H17NO3S MW:339.4082

CAS No. 102210-79-7

1H-Indole, 3-(3-methyl-2-buten-1-yl)-1-(phenylsulfonyl)-

Catalog No.:AG0006Y9 MDL No.:

MF:C19H19NO2S MW:325.4247

CAS No. 102210-80-0

2-Buten-1-one, 3-methyl-1-[1-(phenylsulfonyl)-1H-indol-3-yl]-

Catalog No.:AG0006Y8 MDL No.:

MF:C19H17NO3S MW:339.4082

CAS No. 102211-98-3

1-Butanol, 3-(phenylthio)-

Catalog No.:AG0006Y7 MDL No.:

MF:C10H14OS MW:182.2826

CAS No. 1022112-25-9

Benzeneacetic acid, α-acetyl-2,3-difluoro-6-nitro-, 1,1-dimethylethyl ester

Catalog No.:AG0006XZ MDL No.:MFCD12755704

MF:C14H15F2NO5 MW:315.2694

CAS No. 102212-98-6

Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-, 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]

Catalog No.:AG0006Y6 MDL No.:MFCD00036315

MF:C46H52N5O8P MW:833.9075

CAS No. 102212-99-7

Uridine 5'-(tetrahydrogen triphosphate), 5-bromo-2'-deoxy-, tetrasodium salt (9CI)

Catalog No.:AG0006Y5 MDL No.:

MF:C9H10BrN2Na4O14P3 MW:634.9651

CAS No. 1022128-75-1

1,4-Piperidinedicarboxylic acid, 4-(1-methylethyl)-, 1-(1,1-dimethylethyl) 4-ethyl ester

Catalog No.:AG0006XY MDL No.:MFCD10565656

MF:C16H29NO4 MW:299.4058

CAS No. 1022128-78-4

2-Pyrazinamine, N-(4-methoxyphenyl)-

Catalog No.:AG0006XX MDL No.:MFCD09998892

MF:C11H11N3O MW:201.2245

CAS No. 1022128-80-8

2-Piperazinone, 1-(3-aminophenyl)-

Catalog No.:AG0006XW MDL No.:MFCD10568158

MF:C10H13N3O MW:191.2297

CAS No. 1022128-82-0

2-Piperazinone, 1-(4-aminophenyl)-

Catalog No.:AG0006XV MDL No.:MFCD10568159

MF:C10H13N3O MW:191.2297

CAS No. 1022128-96-6

Benzoic acid, 2-bromo-6-iodo-

Catalog No.:AG0006XU MDL No.:MFCD11036149

MF:C7H4BrIO2 MW:326.9139

CAS No. 1022128-98-8

3-Pyridinepropanoic acid, 5-bromo-

Catalog No.:AG0006XT MDL No.:MFCD11042449

MF:C8H8BrNO2 MW:230.0586

CAS No. 1022128-99-9

5-Isothiazolesulfonamide, 3-methyl-

Catalog No.:AG0006XS MDL No.:

MF:C4H6N2O2S2 MW:178.2326

CAS No. 1022147-21-2

D-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-2,3-difluoro-

Catalog No.:AG0006XR MDL No.:

MF:C14H17F2NO4 MW:301.2859

CAS No. 1022150-11-3

1-Piperidinecarboxylic acid, 3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-, 1,1-dimethylethyl ester, (3R)-

Catalog No.:AG0006XQ MDL No.:

MF:C27H30N6O3 MW:486.5655

CAS No. 1022151-32-1

2-Benzothiazolamine, 6-bromo-5-fluoro-

Catalog No.:AG0006YK MDL No.:MFCD23705697

MF:C7H4BrFN2S MW:247.0875

CAS No. 1022151-47-8

6-Quinolinol, 3-bromo-, 6-acetate

Catalog No.:AG0006YJ MDL No.:MFCD19687231

MF:C11H8BrNO2 MW:266.0907

CAS No. 1022154-85-3

Ethanone, 1-[2-chloro-4-(1H-pyrazol-1-yl)phenyl]-

Catalog No.:AG0006YI MDL No.:

MF:C11H9ClN2O MW:220.6550

CAS No. 1022158-35-5

1H-Indazole, 4-bromo-1-(tetrahydro-2H-pyran-2-yl)-

Catalog No.:AG0006YH MDL No.:MFCD22380249

MF:C12H13BrN2O MW:281.1484

CAS No. 1022158-37-7

3H-IMidazo[4,5-b]pyridine-6-Methanol

Catalog No.:AG0006YG MDL No.:MFCD13183299

MF:C7H7N3O MW:149.1500

CAS No. 1022169-96-5

1H-Isoindole-1-carboxylic acid, 2,3-dihydro-2-[(4-methoxyphenyl)methyl]-3-oxo-, ethyl ester

Catalog No.:AG0006YF MDL No.:

MF:C19H19NO4 MW:325.3585

CAS No. 10222-01-2

Acetamide, 2,2-dibromo-2-cyano-

Catalog No.:AG0006Z3 MDL No.:MFCD00129791

MF:C3H2Br2N2O MW:241.8688

CAS No. 10222-10-3

8-Quinolinethiol, 2-methyl-

Catalog No.:AG0006Z2 MDL No.:

MF:C10H9NS MW:175.2502

CAS No. 10222-47-6

2-Quinolinecarbonitrile, 4-methyl-, 1-oxide

Catalog No.:AG0006Z1 MDL No.:

MF:C11H8N2O MW:184.1940

CAS No. 10222-49-8

Quinoline, 3-chloro-2-methyl-

Catalog No.:AG0006Z0 MDL No.:

MF:C10H8ClN MW:177.6302

CAS No. 10222-53-4

2,3-Quinolinedicarboxaldehyde

Catalog No.:AG0006YZ MDL No.:

MF:C11H7NO2 MW:185.1788

CAS No. 10222-61-4

4-Quinolinecarboxylic acid, 2-butoxy-

Catalog No.:AG0006YY MDL No.:MFCD11527607

MF:C14H15NO3 MW:245.2738

CAS No. 10222-62-5

4-Quinolinecarboxylic acid, 2-methoxy-

Catalog No.:AG0006YX MDL No.:MFCD01550057

MF:C11H9NO3 MW:203.1941

CAS No. 10222-95-4

Benzene, 1,2,4-trimethyl-5-(1-methylethyl)-

Catalog No.:AG0006YW MDL No.:

MF:C12H18 MW:162.2713

CAS No. 102222-08-2

2-Pyrrolidinone, 1,3-dibenzoyl-

Catalog No.:AG0006YV MDL No.:

MF:C18H15NO3 MW:293.3166

CAS No. 102222-10-6

2H-Azepin-2-one, 1,3-dibenzoylhexahydro-

Catalog No.:AG0006YU MDL No.:

MF:C20H19NO3 MW:321.3698

CAS No. 102222-52-6

Benzoic acid, 4-[(diphenylmethylene)amino]-, ethyl ester

Catalog No.:AG0006YT MDL No.:

MF:C22H19NO2 MW:329.3918

CAS No. 102222-53-7

Benzenamine, N-(1,3-diphenyl-2-propyn-1-ylidene)-4-methyl-

Catalog No.:AG0006YS MDL No.:

MF:C22H17N MW:295.3771

CAS No. 102222-55-9

Benzenebutanoic acid, 2,3,4-trimethoxy-γ-oxo-, ethyl ester

Catalog No.:AG0006YR MDL No.:MFCD09801964

MF:C15H20O6 MW:296.3157

CAS No. 102225-38-7

Benzene, 1-[2-(4-butylphenyl)ethynyl]-4-propyl-

Catalog No.:AG0006YQ MDL No.:

MF:C21H24 MW:276.4153

CAS No. 102225-45-6

1,1'-Biphenyl, 4-[2-(4-fluorophenyl)ethynyl]-4'-propyl-

Catalog No.:AG0006YP MDL No.:

MF:C23H19F MW:314.3954

CAS No. 102225-55-8

Benzene, 1-[(4-ethylphenyl)ethynyl]-4-propyl-

Catalog No.:AG0006YO MDL No.:

MF:C19H20 MW:248.3621

CAS No. 102225-88-7

Benzenemethanol, α-methyl-2,4,6-tris(1-methylethyl)-, (αS)-

Catalog No.:AG0006YN MDL No.:MFCD09836213

MF:C17H28O MW:248.4036

CAS No. 102225-89-8

Cyclopropanemethanol, 2-(aminomethyl)-, (1R,2S)-rel-

Catalog No.:AG0006YM MDL No.:MFCD16250074

MF:C5H11NO MW:101.1469

CAS No. 102225-94-5

1,1-Cyclopropanedimethanol, 2-ethenyl-

Catalog No.:AG0006ZK MDL No.:

MF:C7H12O2 MW:128.1690

CAS No. 1022250-67-4

3-Pyridinol, 4-bromo-6-methyl-2-nitro-

Catalog No.:AG0006Z5 MDL No.:MFCD21603643

MF:C6H5BrN2O3 MW:233.0195

CAS No. 102226-40-4

2H-Pyrido[4,3-b]-1,4-oxazin-3(4H)-one

Catalog No.:AG0006ZJ MDL No.:MFCD08062755

MF:C7H6N2O2 MW:150.1347

CAS No. 102226-79-9

Benzene, 4-[(2-chloroethyl)thio]-1,2-dimethoxy-

Catalog No.:AG0006ZI MDL No.:

MF:C10H13ClO2S MW:232.7270

CAS No. 102227-52-1

1,2,4-Oxadiazol-5(2H)-one, 3-(4-pyridinyl)-

Catalog No.:AG0006ZH MDL No.:MFCD12774152

MF:C7H5N3O2 MW:163.1335

CAS No. 102229-10-7

Ethanol, 2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-

Catalog No.:AG0006ZG MDL No.:MFCD09261150

MF:C8H20O2Si MW:176.3287

CAS No. 10223-93-5

1,3-Cyclohexanedicarboxylic acid, 2-(4-hydroxyphenyl)-4,6-dioxo-5-[(phenylamino)carbonyl]-, 1,3-diethyl ester

Catalog No.:AG0006ZM MDL No.:

MF:C25H25NO8 MW:467.4679

CAS No. 10223-94-6

1,3-Cyclohexanedicarboxylic acid, 2-[4-(acetyloxy)phenyl]-4,6-dioxo-5-[(phenylamino)carbonyl]-, 1,3-diethyl ester

Catalog No.:AG0006ZL MDL No.:

MF:C27H27NO9 MW:509.5046

CAS No. 102231-36-7

4H-1-Benzopyran-6-ol

Catalog No.:AG0006ZF MDL No.:

MF:C9H8O2 MW:148.1586

CAS No. 102231-97-0

1,2-Benzenedicarbonitrile, 3,4,5,6-tetrakis(ethylthio)-

Catalog No.:AG0006ZE MDL No.:

MF:C16H20N2S4 MW:368.6034

CAS No. 102232-01-9

1,2-Benzenedicarbonitrile, 3,4,5,6-tetrakis(butylthio)-

Catalog No.:AG0006ZD MDL No.:

MF:C24H36N2S4 MW:480.8160

CAS No. 102233-07-8

Piperazine, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(2-pyridinyl)-, hydrochloride (1:1)

Catalog No.:AG0006ZC MDL No.:

MF:C19H26ClN3O2 MW:363.8816

CAS No. 102233-13-6

Piperazine, 2,5-dimethyl-1-[3-[4-(phenoxymethyl)phenyl]propyl]-

Catalog No.:AG0006ZB MDL No.:

MF:C22H30N2O MW:338.4864

CAS No. 102233-26-1

Methanone, [4-(2-hydroxyethyl)-1-piperazinyl]-10H-phenothiazin-10-yl-, hydrochloride (1:1)

Catalog No.:AG0006ZA MDL No.:

MF:C19H22ClN3O2S MW:391.9149

CAS No. 102233-68-1

2-Butenoic acid, 3-[[2-(3-thienyl)ethyl]amino]-, methyl ester

Catalog No.:AG0006Z9 MDL No.:

MF:C11H15NO2S MW:225.3073

CAS No. 102233-70-5

2-Butenoic acid, 3-(3-buten-1-ylamino)-, methyl ester

Catalog No.:AG0006Z8 MDL No.:

MF:C9H15NO2 MW:169.2209

CAS No. 102234-44-6

Benzofuran, 2-ethyl-7-methoxy-

Catalog No.:AG0006Z7 MDL No.:

MF:C11H12O2 MW:176.2118

CAS No. 1022353-79-2

1-Piperazineacetic acid, 4-[(4-bromophenyl)sulfonyl]-, ethyl ester

Catalog No.:AG0006Z4 MDL No.:MFCD12913973

MF:C14H19BrN2O4S MW:391.2807

CAS No. 102236-13-5

Benzenamine, 3-bromo-4-methoxy-N,N-dimethyl-

Catalog No.:AG0006Z6 MDL No.:

MF:C9H12BrNO MW:230.1017

© 2019 Angene International Limited. All rights Reserved.